Screener
PSCH vs IBB
Invesco S&P SmallCap Health Care ETF vs iShares Biotechnology ETF
Key differences
- PSCH costs 0.15% less per year.
- IBB is significantly larger than PSCH — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IBB has delivered higher annualized returns.
- IBB has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PSCH | IBB | |
|---|---|---|
| Annual cost (TER) | 0.29% | 0.44% |
| Fund size (AUM) | $129M | $7.9B |
| Since | 2010 | 2001 |
| Dividend yield | 0.01% | 0.23% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +12.3% | +40.4% |
| CAGR 3Y | +1.0% | +9.6% |
| CAGR 5Y | -5.7% | +2.9% |
| Sharpe 3Y | -0.01 | 0.38 |
| Volatility 1Y | 20.29% | 19.74% |
| Max drawdown | -47.32% | -39.82% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PSCH and IBB
Explore further